Invesco Ltd. Puma Biotechnology, Inc. Transaction History
Invesco Ltd.
- $600 Billion
- Q3 2025
A detailed history of Invesco Ltd. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 63,817 shares of PBYI stock, worth $315,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,817
Previous 49,982
27.68%
Holding current value
$315,894
Previous $171,000
91.23%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PBYI
# of Institutions
135Shares Held
35.2MCall Options Held
264KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.4 Million11.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$10.6 Million0.02% of portfolio
-
Acadian Asset Management LLC Boston, MA2.05MShares$10.2 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $226M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...